OSE Immunotherapeutics Stock
Stocks
OSE
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Paris
18:55:00 26/08/2026 +03
|
After hours 21:32:34 | |||
| 3.216 EUR | +0.12% |
|
3.212 | -0.12% |
| 08-19 | Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine | RE |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| Market Cap | 75.55M 88.02M 70.91M 64.76M 122M 8.4B 123M 839M 325M 4.24B 330M 323M 14.03B | P/E 2026 * |
-2.47x | P/E 2027 * | -2.83x |
|---|---|---|---|---|---|
| Enterprise Value | 116M 136M 109M 99.73M 188M 12.93B 189M 1.29B 501M 6.52B 509M 498M 21.6B | EV / Sales 2026 * |
23.7x | EV / Sales 2027 * | 13.2x |
| Free-Float |
78.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 day | +0.12% | ||
| 1 week | -4.68% | ||
| Current month | +0.31% | ||
| 1 month | +0.31% | ||
| 3 months | -34.53% | ||
| 6 months | -27.40% | ||
| Current year | -37.55% |
| 1 week | 3.16 |  | 3.44 |
| 1 month | 3.16 | | 3.54 |
| Current year | 2.87 | | 5.9 |
| 1 year | 2.87 | | 7.7 |
| 3 years | 2.71 | | 11.58 |
| 5 years | 2.7 | | 13.68 |
| 10 years | 2.7 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 02/10/2025 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 20/08/2025 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 20/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 31/05/2016 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 14/06/2017 |
| Director/Board Member | - | 22/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/13/24 A | Sell | Director | 30,000 | 0.1375% | ||
| 11/12/24 A | Sell | Chief Administrative Officer | 10,000 | 0.0458% | ||
| 6/21/24 A | Fiscal year | Director | 10,000 | 0.0459% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -4.68% | -47.36% | +18.02% | 88.16M | |
| -1.01% | +1.48% | +1.66% | +23.62% | 51.65B | |
| +1.30% | +0.58% | +479.20% | +569.23% | 45.31B | |
| +0.77% | +4.99% | +39.39% | +18.00% | 42.7B | |
| -0.10% | -0.30% | +21.64% | +85.93% | 42.79B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 32.87B | |
| +0.88% | +1.76% | +31.90% | +136.57% | 17.14B | |
| -0.78% | -3.02% | - | - | 16.61B | |
| -1.70% | +3.06% | +11.11% | +28.57% | 15.01B | |
| -0.14% | +2.36% | +81.32% | +49.35% | 14.21B | |
| Average | -0.31% | +2.38% | +70.34% | +108.98% | 27.84B | |
| Weighted average by Cap. | -0.24% | +2.74% | +102.14% | +139.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.9M 5.71M 4.6M 4.2M 7.93M 545M 7.97M 54.43M 21.09M 275M 21.44M 20.97M 910M | 10.53M 12.27M 9.88M 9.03M 17.04M 1.17B 17.12M 117M 45.33M 590M 46.06M 45.06M 1.96B |
| Net income | -30.59M -35.64M -28.71M -26.22M -49.48M -3.4B -49.72M -340M -132M -1.71B -134M -131M -5.68B | -21.47M -25.01M -20.15M -18.4M -34.73M -2.39B -34.9M -238M -92.41M -1.2B -93.91M -91.87M -3.99B |
| Net Debt | 40.79M 47.53M 38.29M 34.97M 65.99M 4.53B 66.31M 453M 176M 2.29B 178M 175M 7.57B | 63.08M 73.5M 59.21M 54.08M 102M 7.01B 103M 701M 272M 3.54B 276M 270M 11.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/08/26 | €3.216 | +0.12% | 57,101 |
| 25/08/26 | €3.212 | +0.75% | 72,226 |
| 24/08/26 | €3.188 | -4.38% | 112,844 |
| 21/08/26 | €3.334 | -0.30% | 115,625 |
| 20/08/26 | €3.344 | -0.89% | 127,004 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
Select your edition
All financial news and data tailored to specific country editions
